Cancercare Manitoba

Winnipeg, MB

UEI
N2LLXRLYCZS7
CAGE
L0A11
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Public Health Institute Per Case Reimbursement - Work Order U10CA180886 $69,050
Public Health Institute Workload Intensity - Work Order U10CA180886 $45,225
Public Health Institute COG Per Case Reimbursement - Addenda U10CA180886 $44,000
Public Health Institute Per Case Reimbursement - Addenda U10CA180886 $47,500

Similar vendors

Vendor Location Primary NAICS
Cancer Support Community Arizona UEI DABUQT6PJLN8 Phoenix, AZ —
Tristar Centennial Medical Center UEI SC7LBWNTCKQ3 Nashville, TN —
Clinical And Radiation Oncology Society Of Zambia UEI XGJ6XW5J5UB5 Lusaka, Lusaka Province —
Boulder Valley Womens Health Center Inc. UEI ZVWWHNXG3795 Boulder, CO —
Exomira Medicine Inc. UEI NPQUP274QX75 Chicago, IL —

About the company

Cancercare Manitoba, a Canadian nonprofit health-care organization headquartered in Winnipeg, Manitoba, operates exclusively as a federal grant subrecipient, performing oncology-related work under awards from the Department of Health and Human Services National Institutes of Health National Cancer Institute. The vendor holds no prime grants or contracts; all four recent federal awards flow through the Public Health Institute as prime grantee.

Cancercare Manitoba's federal footprint is minimal and specialized. Four sub-awards total $206 thousand combined obligation over the past eighteen months, awarded in November 2023, October 2024, January 2025, and May 2025. The work centers on cancer-care delivery and reimbursement models — per-case reimbursement mechanisms, workload-intensity measurement, and cost-of-goods addenda — structured as work orders and addenda under the NCI grantor relationship. All four sub-awards name the Public Health Institute as the prime grantee, indicating Cancercare Manitoba participates in a structured sub-award arrangement rather than as an independent federal recipient. The organization serves a single federal customer agency (100% of awards to NCI via HHS). Activity appears steady at one to two awards per year, with the most recent sub-award dated May 2025. No parent vehicles, IDIQs, GWACs, or BPAs appear in the footprint — the relationship is direct sub-award under grant rather than task-order based. Given the organization's Canadian domicile, nonprofit status, and exclusive subrecipient posture on health research grants, the vendor likely functions as a research or service-delivery partner for cancer-care studies rather than as a commercial federal contractor; the award structure reflects grant pass-through rather than commercial procurement.

Quick answers

Is Cancercare Manitoba registered in SAM.gov?

Yes. Cancercare Manitoba's SAM.gov registration is active through May 28, 2027.

On GovTribe

See Cancercare Manitoba's full federal record

  • Similar vendors